接受早产儿视网膜病变治疗的6.5岁儿童眼科结局:一项瑞典登记研究
该瑞典全国早产儿视网膜病变登记研究分析了2007至2014年间接受治疗的270名儿童中232名在6.5岁时的随访数据,发现视力损害占14%、斜视占38%、屈光不正占52%、显著眼部问题占65%。再次治疗是视力损害和屈光不正的危险因素,男性性别和新生儿脑病变是斜视的危险因素,出生时胎龄每增加一周可降低屈光不正、斜视和显著眼部问题的风险。
要点
- 接受早产儿视网膜病变治疗的儿童在6.5岁时眼部问题发生率高,视力损害14%、斜视38%、屈光不正52%、显著眼部问题65%。
- 再次治疗是视力损害和屈光不正的危险因素。
- 男性性别和新生儿脑病变是斜视的危险因素,出生时胎龄每增加一周可降低屈光不正、斜视和显著眼部问题风险。
核心结论
- 接受早产儿视网膜病变治疗的儿童中眼部问题发生率高,强调需要长期随访。
- 早产儿视网膜病变再次治疗是视力损害的危险因素,强调首次治疗准确对长期眼科结局的重要性。
研究设计与样本
- 基于瑞典全国早产儿视网膜病变登记处的登记研究,纳入2007至2014年间出生并接受早产儿视网膜病变治疗的270名儿童,其中232名有随访数据。
- 从登记处获取早产儿视网膜病变、治疗和眼科结局数据,分析视力、屈光不正、斜视、视力损害及显著眼部问题,并分析性别、胎龄、出生体重标准差评分、治疗和再次治疗次数、首次治疗时出生后日龄和矫正胎龄等危险因素。
主要发现
- 232名儿童中,视力损害(视力>0.5 logMAR)32名(14%),斜视82名(38%),屈光不正114名(52%),显著眼部问题143名(65%)。
- 再次治疗是视力损害和屈光不正的危险因素。
- 男性性别和新生儿脑病变是斜视的危险因素。
- 出生时胎龄每增加一周可降低屈光不正、斜视和显著眼部问题的风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To determine the ophthalmological outcome at 6.5 years of age in children treated for retinopathy of prematurity (ROP), and registered in the national Swedish National Register for ROP register. METHODS: Data on ROP, treatment and ophthalmological outcome were retrieved from the register. Visual acuity (VA), refractive errors and strabismus, together with visual impairment (VI) and any significant eye problem, defined as VA >0.5 logarithm of the minimal angle of resolution (logMAR) and/or strabismus and/or any refractive error were analysed. Risk factors such as sex, gestational age (GA), birth weight SD score, number of treatments and retreatments, postnatal age and postmenstrual age at first treatment were analysed. RESULTS: Follow-up data were available in 232 of 270 children born between 2007 and 2014 who had been treated for ROP. VI (VA >0.5 logMAR) was found in 32 (14%), strabismus in 82 (38%), refractive errors in 114 (52%) and significant eye problem in 143 (65%) children. Retreatment was a risk factor for VI and refractive errors. Male sex and neonatal brain lesion were risk factors for strabismus. An additional week of GA at birth reduced the risk for refractive errors, strabismus and significant eye problems. CONCLUSION: The results of the present study revealed a high number of eye problems in children treated for ROP, emphasising the need for long-term follow-up. Retreatment of ROP was a risk factor for VI, and emphasises the importance of an accurate first treatment for the long-term ophthalmological outcome.
引用
- Larsson E, Hellström A, Tornqvist K, et al. Ophthalmological outcome of 6.5 years children treated for retinopathy of prematurity: a Swedish register study. Br J Ophthalmol. 2023. PMID: 36717199. doi:10.1136/bjo-2022-322022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。